GTH Stock - Genetron Holdings Limited
Unlock GoAI Insights for GTH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $650.71M | $531.95M | $424.49M | $323.43M | $225.18M |
| Gross Profit | $281.43M | $337.97M | $260.22M | $144.99M | $92.73M |
| Gross Margin | 43.2% | 63.5% | 61.3% | 44.8% | 41.2% |
| Operating Income | $-631,620,000 | $-480,816,000 | $-253,533,000 | $-306,589,000 | $-232,976,000 |
| Net Income | $-883,889,000 | $-438,404,000 | $-198,105,000 | $-321,492,000 | $-464,993,000 |
| Net Margin | -135.8% | -82.4% | -46.7% | -99.4% | -206.5% |
| EPS | $-28.53 | $-4.76 | $-3.29 | $-4.65 | $-6.73 |
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Visit WebsiteEarnings History & Surprises
GTHEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 10, 2024 | — | — | — | — |
Q1 2024 | Jan 18, 2024 | — | — | — | — |
Q4 2023 | Dec 19, 2023 | $-0.46 | — | — | — |
Q3 2023 | Sep 21, 2023 | $-0.55 | — | — | — |
Q2 2023 | Jun 26, 2023 | $-0.60 | $-0.30 | +50.2% | ✓ BEAT |
Q1 2023 | Jan 16, 2023 | $-0.60 | $-0.94 | -56.4% | ✗ MISS |
Q4 2022 | Oct 12, 2022 | $-0.22 | $-1.11 | -404.5% | ✗ MISS |
Q3 2022 | Aug 26, 2022 | — | $-0.38 | — | — |
Q2 2022 | Jun 2, 2022 | $-0.15 | $-0.84 | -460.0% | ✗ MISS |
Q1 2022 | Mar 29, 2022 | $-0.13 | $-0.78 | -480.4% | ✗ MISS |
Q4 2021 | Nov 30, 2021 | — | $-0.54 | — | — |
Q3 2021 | Aug 24, 2021 | — | $-0.39 | — | — |
Q2 2021 | May 24, 2021 | $-0.65 | $-0.57 | +12.3% | ✓ BEAT |
Q1 2021 | Mar 25, 2021 | $-0.11 | $-0.30 | -172.7% | ✗ MISS |
Q4 2020 | Nov 9, 2020 | $-0.10 | $-0.21 | -110.0% | ✗ MISS |
Q3 2020 | Aug 6, 2020 | $-0.09 | $-0.57 | -533.3% | ✗ MISS |
Q2 2020 | Jun 4, 2020 | — | $-0.28 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.19 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.56 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.29 | — | — |
Latest News
Frequently Asked Questions about GTH
What is GTH's current stock price?
What is the analyst price target for GTH?
What sector is Genetron Holdings Limited in?
What is GTH's market cap?
Does GTH pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GTH for comparison